Watch and track your favorite playlist.
Curated by: Ben Bikman (139 videos)
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Tirzepatide activates both GLP-1 and GIP receptors, producing weight loss primarily through appetite suppression, slower gastric emptying, reduced cravings, and improved insulin sensitivity—not by forcing the pancreas to make more insulin. Dr. Bikman argues that its best use may be as a temporary tool to help people regain control of food choices and lower the insulin-driving habits that caused metabolic dysfunction. Summary: In this mini-lecture, Dr. Bikman explains tirzepatide, the dual-incretin drug that activates both GLP-1 and GIP receptors. While it is often described as a drug that improves glucose by increasing insulin, Dr. Bikman argues that this explanation misses the bigger metabolic picture. He begins by reviewing the incretin effect, where oral glucose produces a stronger insulin response than the same glucose given intravenously because the gut releases hormones such as GLP-1 and GIP. GLP-1 reduces appetite, slows gastric emptying, suppresses glucagon, and helps regulate glucose, while GIP has traditionally been viewed as more fat-storing because of its actions on fat cells. Ben then resolves the “GIP paradox”: blocking GIP can cause weight loss in animals, yet activating GIP through tirzepatide also causes weight loss. The key, he argues, is insulin. GIP can amplify fat storage only when insulin is elevated, but tirzepatide lowers fasting insulin, reduces meal-related insulin demand, and reduces cravings for foods that drive insulin high. In that lower-insulin context, GIP may support healthier fat tissue function, improve adiponectin, reduce adipose hypoxia, and allow higher GLP-1 activity with better tolerability. The practical takeaway is that tirzepatide should not be viewed as a magic weight-loss injection or a permanent substitute for lifestyle change. Used wisely, it may serve as a temporary tool to reduce carbohydrate cravings, improve satiety, lower insulin demand, and help people relearn healthier eating patterns. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:03 — Introduction: Tirzepatide and the Incretin System 02:06 — GLP-1 and GIP: The Two Incretin Hormones 04:10 — GLP-1’s Effects on Appetite, Glucagon, and Gastric Emptying 05:13 — What Tirzepatide Is 07:19 — Why Tirzepatide Is Not Simply “Raising Insulin” 08:20 — Tirzepatide Improves Insulin Sensitivity 10:54 — The Insulin-Sparing Effect 13:13 — How Tirzepatide Reduces Food Intake 15:44 — Appetite Suppression and Delayed Gastric Emptying 17:36 — The GIP Paradox 18:35 — Why Insulin Determines Whether GIP Stores Fat 22:18 — GIP’s Role in Appetite and Fat Tissue Function 25:37 — Why Dual Activation May Outperform GLP-1 Alone 29:00 — What Tirzepatide Really Does Metabolically 30:08 — Best Use Case: A Tool to Relearn Eating Patterns NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Tirzepatide #GLP1 #GIP #Incretins #InsulinResistance #MetabolicHealth #WeightLossScience #InsulinSensitivity #BloodSugarControl #Semaglutide #Mounjaro #Zepbound #AppetiteControl #GastricEmptying #CarbCravings #Adiponectin #FatLoss #DrBenBikman #MetabolicClassroom #MetabolismMatters Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884 Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)